1. Home
  2. AMST vs ACON Comparison

AMST vs ACON Comparison

Compare AMST & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amesite Inc.

AMST

Amesite Inc.

HOLD

Current Price

$1.07

Market Cap

6.7M

Sector

Technology

ML Signal

HOLD

Logo Aclarion Inc.

ACON

Aclarion Inc.

HOLD

Current Price

$2.39

Market Cap

7.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMST
ACON
Founded
2017
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
7.4M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
AMST
ACON
Price
$1.07
$2.39
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
105.7K
62.8K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
40.46
99.82
EPS
N/A
N/A
Revenue
$110,459.00
$75,730.00
Revenue This Year
N/A
$87.22
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
65.62
52 Week Low
$0.77
$1.95
52 Week High
$4.78
$12.03

Technical Indicators

Market Signals
Indicator
AMST
ACON
Relative Strength Index (RSI) 53.14 45.51
Support Level $0.90 $2.38
Resistance Level $1.09 $2.50
Average True Range (ATR) 0.09 0.18
MACD 0.02 0.01
Stochastic Oscillator 43.76 27.59

Price Performance

Historical Comparison
AMST
ACON

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.

Share on Social Networks: